These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 18607263)

  • 1. Comparison of epidermal growth factor and heparin-binding epidermal growth factor-like growth factor for prevention of experimental necrotizing enterocolitis.
    Dvorak B; Khailova L; Clark JA; Hosseini DM; Arganbright KM; Reynolds CA; Halpern MD
    J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):11-8. PubMed ID: 18607263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats.
    Feng J; El-Assal ON; Besner GE
    J Pediatr Surg; 2006 Jan; 41(1):144-9; discussion 144-9. PubMed ID: 16410124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-binding epidermal growth factor-like growth factor reduces intestinal apoptosis in neonatal rats with necrotizing enterocolitis.
    Feng J; El-Assal ON; Besner GE
    J Pediatr Surg; 2006 Apr; 41(4):742-7; discussion 742-7. PubMed ID: 16567187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis.
    Clark JA; Lane RH; Maclennan NK; Holubec H; Dvorakova K; Halpern MD; Williams CS; Payne CM; Dvorak B
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G755-62. PubMed ID: 15528252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model.
    Dvorak B; Halpern MD; Holubec H; Williams CS; McWilliam DL; Dominguez JA; Stepankova R; Payne CM; McCuskey RS
    Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G156-64. PubMed ID: 11751169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-binding EGF-like growth factor (HB-EGF) and necrotizing enterocolitis.
    Feng J; El-Assal ON; Besner GE
    Semin Pediatr Surg; 2005 Aug; 14(3):167-74. PubMed ID: 16084404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment.
    Clark JA; Doelle SM; Halpern MD; Saunders TA; Holubec H; Dvorak K; Boitano SA; Dvorak B
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G938-49. PubMed ID: 16798726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis.
    Feng J; Besner GE
    J Pediatr Surg; 2007 Jan; 42(1):214-20. PubMed ID: 17208569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor reduces hepatic sequelae in experimental necrotizing enterocolitis.
    Halpern MD; Holubec H; Clark JA; Saunders TA; Williams CS; Dvorak K; Dvorak B
    Biol Neonate; 2006; 89(4):227-35. PubMed ID: 16319449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing, route, and dose of administration of heparin-binding epidermal growth factor-like growth factor in protection against intestinal ischemia-reperfusion injury.
    Martin AE; Luquette MH; Besner GE
    J Pediatr Surg; 2005 Nov; 40(11):1741-7. PubMed ID: 16291163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical neonatal rat studies of heparin-binding EGF-like growth factor in protection of the intestines from necrotizing enterocolitis.
    Radulescu A; Zorko NA; Yu X; Besner GE
    Pediatr Res; 2009 Apr; 65(4):437-42. PubMed ID: 19127210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of heparin-binding epidermal growth factor-like growth factor on the growth of cultured human uterine leiomyoma cells and myometrial cells.
    Wang J; Ohara N; Takekida S; Xu Q; Maruo T
    Hum Reprod; 2005 Jun; 20(6):1456-65. PubMed ID: 15760954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-binding epidermal growth factor-like growth factor protects rat intestine from ischemia/reperfusion injury.
    Pillai SB; Hinman CE; Luquette MH; Nowicki PT; Besner GE
    J Surg Res; 1999 Dec; 87(2):225-31. PubMed ID: 10600353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-binding EGF-like growth factor downregulates expression of adhesion molecules and infiltration of inflammatory cells after intestinal ischemia/reperfusion injury.
    Xia G; Martin AE; Besner GE
    J Pediatr Surg; 2003 Mar; 38(3):434-9. PubMed ID: 12632363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-binding epidermal growth factor-like growth factor is an autocrine mediator of human prostate stromal cell growth in vitro.
    Duque JL; Adam RM; Mullen JS; Lin J; Richie JP; Freeman MR
    J Urol; 2001 Jan; 165(1):284-8. PubMed ID: 11125426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-binding epidermal growth factor-like growth factor and mesenchymal stem cells act synergistically to prevent experimental necrotizing enterocolitis.
    Yang J; Watkins D; Chen CL; Bhushan B; Zhou Y; Besner GE
    J Am Coll Surg; 2012 Oct; 215(4):534-45. PubMed ID: 22819639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-binding epidermal growth factor-like growth factor downregulates expression of activator protein-1 transcription factor after intestinal ischemia-reperfusion injury.
    Luo CC; Ming YC; Chao HC; Chu SM; Pang ST
    Neonatology; 2011; 99(4):241-6. PubMed ID: 21063128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of epidermal growth factor and other growth factors in the prevention of necrotizing enterocolitis.
    Nair RR; Warner BB; Warner BW
    Semin Perinatol; 2008 Apr; 32(2):107-13. PubMed ID: 18346534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue distribution and plasma clearance of heparin-binding EGF-like growth factor (HB-EGF) in adult and newborn rats.
    Feng J; Mehta VB; El-Assal ON; Wu D; Besner GE
    Peptides; 2006 Jun; 27(6):1589-96. PubMed ID: 16364500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril reduces the severity of bowel damage in a neonatal rat model of necrotizing enterocolitis.
    Zani A; Eaton S; Leon FF; Malerba A; Hall NJ; De Coppi P; Smith VV; Pierro A
    J Pediatr Surg; 2008 Feb; 43(2):308-14. PubMed ID: 18280280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.